Highlights

Share

Program Content

Activities

  • IAS Preview
    IAS 2019: A Preview of Key Data to Be Presented in Mexico City
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 16, 2019

  • IAS 2019: Looking Ahead
    Looking Ahead From IAS 2019: New Hope For HIV Prevention and Treatment
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 26, 2019

  • LA Injectable CAB + RPV
    Long-Acting Injectable ART: What Do Patients Think?
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 12, 2019

  • New Data From IAS 2019
    Clinical Impact of New Data From IAS 2019
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 02, 2019

Activities

ANRS 12300 Reflate TB2
ANRS 12300 Reflate TB2: RAL + 3TC/TDF Does Not Achieve Noninferior Efficacy vs EFV + 3TC/TDF at Wk 48 in ART-Naive Adults With HIV and TB
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 23, 2019

BRIGHTE
BRIGHTE: Wk 96 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced Patients Failing Current ART
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2019

ATLAS: PROs With LA-ART
ATLAS: Patient-Reported Outcomes From Phase III Study of Switch to Long-Acting Injectable Cabotegravir + Rilpivirine in Virologically Suppressed Patients
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 25, 2019

Switch to BIC/FTC/TAF
Study 380-4030: Switch to BIC/FTC/TAF Noninferior to DTG + FTC/TAF in Virologically Suppressed Adults
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2019

Tsepamo
Tsepamo: DTG Exposure at Conception Associated With Smaller Increase in Incidence of Neural Tube Defects in Updated Analysis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2019

DISCOVER: TFV-DP Levels
DISCOVER: More Rapid and Sustained Protective Levels of TFV-DP With FTC/TAF vs FTC/TDF as PrEP
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2019

Islatravir + Doravirine
DRIVE2Simplify, Part 2: Wk 48 Results From Phase IIb study of Islatravir + Doravirine vs DOR/3TC/TDF in ART-Naive Adults
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2019

TANGO
TANGO: Switch to DTG/3TC Noninferior to Continued TAF-Based ART in Virologically Suppressed Adults
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2019

GEMINI
GEMINI-1 and -2: DTG + 3TC Noninferior to DTG + FTC/TDF at Wk 96 in ART-Naive Adults
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2019

ADVANCE
ADVANCE: DTG + FTC/(TAF or TDF) Noninferior to EFV/FTC/TDF in ART-Naive Patients in South Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2019

Provided by

ProCE Banner

Supporters

Gilead

ViiV Healthcare

Partners

IAS 2018

ProCE Banner

IAS 2019

ProCE Banner